There are approximately 20 000 new patients diagnosed with myeloma in the United States each year.1 With the availability of better treatments and resultant improved survival, there are currently ...
CPT copyright 2010 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Editor’s Note: This article ...
As many of the subjects participating in the outcomes study underwent multiple sessions, clustering of sessions within subjects was addressed by using mixed models with a random effect for subject for ...
SAN JOSE, Calif.--(BUSINESS WIRE)--DFine, Inc., developer of minimally invasive solutions for treating vertebral pathologies, announced today that Robert Pflugmacher, M.D., of University Hospital in ...
MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE:MDT) today announced that Noridian Administrative Services, a major Medicare Administrative Contractor providing Medicare insurance coverage in 11 ...
A study of 69,000 Medicare patient records led by Johns Hopkins researchers shows that people with spine compression fractures who undergo operations to strengthen back bones with cement survive ...
October 1, 2010 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a vertebral augmentation device (Parallax Contour; Arthrocare Corp) for vertebral void creation followed by ...
Please provide your email address to receive an email when new articles are posted on . Vertebral compression fractures are most commonly caused by osteoporosis, but these injuries can also result ...
ArthroCare Corp., a developer of state-of-the-art, minimally invasive surgical products, announced in a press release that it has received clearance from the U.S. Food and Drug Administration (FDA) to ...
"Routine use of vertebral augmentation for pain relief after vertebral fracture is not supported by current data," a new report commissioned by the American Society for Bone and Mineral Research ...
BOULDER, Colo.--(BUSINESS WIRE)--Crosstrees Medical, Inc. today announced that it has completed enrollment of the company sponsored pivotal IDE study, “Clinical Evaluation of the Crosstrees™ PVA Pod ...
BOULDER, Colo.--(BUSINESS WIRE)--Crosstrees Medical, Inc. today announced that it has completed enrollment of the company sponsored pivotal IDE study, "Clinical Evaluation of the Crosstrees™ PVA Pod ...